Down 11% on Oct 30.
Up 33% over the year to Nov 9 while the S&P 500 rose 12%; down 11% on Oct 30.
5 reasons, from its filings, with the timeline and its peers, for Pro members.
SXT's Quality Score fell 2 points on Tue, Nov 10, to 8. It did not trade higher than the day before (2 chart checks stopped).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
| The company | Profit up 22% to $169M |
| Latest filing | 8-K, Nov 4 |
After its last 4 reports it closed +4.2% on average, higher 2 of 4 times.
Averagefor quality, not price, 2 of 14 chart checks firingWhat the Quality Score means
Well below its recent run. SXT scores 8 today, against a median of 14 over its last 20 recorded sessions.
SXT is #3 of 14 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score |
Free cash flow over four quarters: SXT -$17.5M, IFF $501M, NEU $383M.
Expected to report Fri Feb 12, before the open (in 94 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
Sales of $455.8M, 11% more than a year ago; a profit of $1.13 a share, from $0.87.
“The Group’s revenue increase was driven primarily by higher prices and volume growth.”
| Line | Q3 2026 | Q2 2026 | Q3 2025 |
|---|---|---|---|
| Food & Pharmaceutical Colors | $164M | $168M | $134M |
Each quarter's sales and their share of its total. Figures as filed (SEC filing, Oct 30)
No outlook figures read from this release.
“The Group’s revenue increase was driven primarily by strong volume growth.”
From its results filing (SEC filing · Oct 30)
Sales grew 3.9% a year over 5 years, fiscal 2020 to 2025.
Pays $1.64 a share a year.
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Oct 30, 2026 | -14.8% | -10.6% | -9.0% |
| Jul 24, 2026 | +2.5% | +8.3% | +5.9% |
| Apr 24, 2026 | +9.3% | +24.1% | +14.5% |
Sales grew in six of the last seven years, to $1.6B in 2025. It made a profit in each of the eight years.
RSI 41.2, MACD below signal, below its 50-day, above its 200-day. Not scored.
Its free cash flow over the last four quarters was -$17.5M, while it paid dividends.
| Dividend | $1.64 a share a year |
| Paid out | About $70.2M a year |
| Free cash flow | -$17.5M |
2 insiders sold $201K across 2 filings in the last 6 months. No open-market buys on record. The newest:
Officers and directors with a Form 4 in the last 12 months.
Sensient Technologies Corp manufactures and markets natural and synthetic colors, flavors, and other specialty ingredients. Sensient's offerings are predominantly applied to consumer-facing products, including food and beverage, cosmetics and pharmaceuticals, nutraceuticals, and personal care industries. Its principal products are flavors, flavor enhancers, ingredients, extracts, and bionutrients, essential oils, dehydrated vegetables and other food ingredients, natural and synthetic food and beverage colors, and others. The company's reportable segments are: Flavors & Extracts, which derive key revenue, Color, Asia Pacific, and Corporate and Other. Geographically, the company generates maximum revenue from North America, followed by Europe, Asia-Pacific, and other regions.
“All Company products are sold in highly competitive markets.”
SXT scores 8 today, which Breakaway calls Average. It is #3 of 14 in Industrial Organic Chemicals by Quality Score, with 2 of 14 chart checks firing. Down 11% on Oct 30. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
SXT scores 8 today, which Breakaway calls Average (6 to 10). That is #3 of 14 in Industrial Organic Chemicals by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind SXT's 8.
2 insiders sold $201K across 2 filings in the last 6 months. No open-market buys on record. The newest is Mario Ferruzzi, Director, who sold $155K on Aug 5. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Thursday morning. No account. No card. Then keep going with a free account.